SIRO Clinpharm named Indian CRO of the Year 2012

Monday, October 1, 2012 09:20 AM

SIRO Clinpharm, a drug development solutions provider, has been awarded the 'Indian CRO of the Year 2012' by Frost & Sullivan, a global growth partnership and consulting firm.

The award was received by Gopakumar Menon, CEO, SIRO Clinpharm on behalf of the employees. "I am proud to receive this award as an ambassador of exceptional professionals across three continents, whose daily pursuit of excellence has resulted in SIRO Clinpharm receiving this award for two consecutive years," he said.

Ajaykumar Sharma, associate director of pharma and biotech, South Asia and Middle East, Frost & Sullivan, added, "With all the regulatory challenges which had taken off the sheen from the Indian CRO industry in the last few years, it is amazing to see a company repeating this feat for the second year in a row.”

The award is a testimony to SIRO Clinpharm's commitment in supporting its stakeholders through ethical, transparent and best-in-class services.

"As the Indian markets open to the western world, there are a number of challenges we face not just as a company but as an industry,” said Vatsal Shah, head of medical writing and pharmacovigilance, SIRO. “However, we have been able to convert these challenges into opportunities by ensuring process excellence, improving service delivery and focusing on training and development of our resources—thus, delivering a spectrum of services that is unique to the industry.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 21

As job growth in drug development sector soars, more employees are seeking new opportunities

U.K. study: Prisoners should have the right to participatein clinical trials on moral grounds, for healthcare access

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs